Moelis & Co (MC) Stock Analysis

Verdict: WATCH (do not buy)

Cyclical M&A rebound and 10.4% FCF yield offer valuation support, but consecutive 2026 EPS misses and a high beta (1.87) cap near-term upside.

Investment score: 51/100

Analysis as of

Is Moelis & Co stock worth reviewing? The TradeMates thesis

Strong free cash flow conversion ($539.97M in 2025; 10.4% TTM yield) and expected 2027 deal recovery (EPS forecast $3.94) provide medium-term support. However, consecutive 2026 EPS misses (-11.52% in Q1; -1.19% in Q2), a high Beta of 1.87, and a premium P/E relative to peers (18.59x vs peer median 14.36x) justify a neutral stance.

7-factor investment score

Moelis & Co opportunities and risks

What speaks for MC

What speaks against MC

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
MC18.6x2.7x13.5x69.9%14.5%10.4%
VIRT7.4x3.1x8.3x55.4%16.8%3.3%
HLI20.8x3.5x14.4x50.8%16.1%5.5%
SNEX10.7x0.0x9.4x2.6%0.3%64.8%
BGC28.3x1.7x12.8x80.0%5.9%6.9%
PIPR14.4x2.1x8.3x96.5%14.6%13.7%
Peer median14.4x2.1x9.4x55.4%14.6%6.9%

Frequently asked questions about Moelis & Co (MC)

Is MC stock a good investment?

The TradeMates model rates Moelis & Co as WATCH (do not buy) with an investment score of 51/100. Strong free cash flow conversion ($539.97M in 2025; 10.4% TTM yield) and expected 2027 deal recovery (EPS forecast $3.94) provide medium-term support. However, consecutive 2026 EPS misses (-11.52% in Q1; -1.19% in Q2), a high Beta of 1.87, and a premium P/E relative to peers (18.59x vs peer median 14.36x) justify a neutral stance. This is algorithmic model output, not personal investment advice.

Is MC stock a buy?

The TradeMates model verdict for MC is WATCH (do not buy) with an investment score of 51/100. Treat this as a model signal to review, not a personal buy recommendation.